\documentclass[10pt,a4paper,ragged2e,withhyper]{altacv}
\geometry{left=1.25cm,right=1.25cm,top=1.5cm,bottom=1.5cm,columnsep=1.2cm}

% Define colors
\definecolor{VividPurple}{HTML}{3E0097}
\colorlet{heading}{VividPurple}
\colorlet{accent}{VividPurple}

\begin{document}

% --- Contact Information ---
\name{Vinod Devaraji}
\tagline{Innovative Drug Hunter | Champion of AI/ML-Driven Drug Discovery}
\photoR{3.2cm}{vinod}
\personalinfo{
    \email{donniv86@gmail.com}
    \phone{+91-6364817778}
    \location{Bangalore, India}
    \linkedin{linkedin.com/in/vinod-devaraji}
    \orcid{0000-0002-9355-3995}
}

\makecvheader

\cvsection{Personal Summary}
Strategic computational chemist with 13+ years of experience advancing drug discovery through AI/ML, cheminformatics, and physics-based molecular modeling. Proven track record in hit-to-lead optimization, DMTA cycle automation, and predictive model development across oncology, metabolic, and infectious diseases. Expert in active learning, virtual libraries, FEP+, MD, and deep learning–based ADME/Tox. Skilled collaborator and team leader in CRO, biotech, and academic partnerships.



% --- Professional Experience (Quantified and Focused) ---
\cvsection{Experience}

\cvevent{Senior Scientist II}{Schrödinger}{Mar 2020 -- Present}{Bangalore, India}
\begin{itemize}[leftmargin=*,labelsep=5pt,itemsep=2pt,parsep=0pt] % Improved list formatting
    \item Led active learning–based virtual screening campaigns using large molecular databases for faster hit enrichment.
    \item Developed and managed large scale compound libraries and automated workflows aligning with Make-on-Demand strategies.
    \item Designed predictive deep learning models for toxicity profiling, improving early-stage safety assessment.
    \item Expertise in cheminformatics descriptors, structure/ligand-based modeling, and generative chemistry workflows.
    \item Proficient in Python, reproducible research practices, and deployment on HPC/cloud environments in PyApp Team.
    \item Presented complex scientific findings to multidisciplinary teams and executive stakeholders.
\end{itemize}

\cvevent{Senior Scientist}{Schrödinger}{Jan 2016 -- Mar 2020}{Bangalore, India}
\begin{itemize}
    \item \textbf{Target Prioritization using EDA proteomics data:} Developed custom automations for target prioritization and hit /lead optimization in the research area of various enzymes.
    \item \textbf{Global Deployment of Computational Tools:} Envisioning data digitlization I successfully coordinated with global research partners to deploy research data lakes of research team, creating advanced automated analytics and computational tools in research workflows, standardizing workflows and improving data sharing across research sites.
    \item \textbf{Target Identification and Validation:} Spearheaded cross-functional collaborations with medicinal chemists and biologists to identify and validate novel therapeutic targets in oncology, leading to major \textbf{8 new drug discovery projects for hit and lead optimisation projects using enterprise informatics tools}.
\end{itemize}

\cvevent{Junior Application Scientist}{Schrödinger}{May 2011 -- Jan 2016}{Bangalore, India}
\begin{itemize}
    \item \textbf{Trained over 10 researchers annually} on advanced computational methods, including molecular docking, dynamics, 3D QSAR, and cheminformatics, empowering them to effectively utilize Schrödinger's software.
    \item \textbf{Developed impactful case studies} showcasing real-world applications of computational techniques, driving software adoption and establishing best practices for optimized computational workflows.
    \item \textbf{Resolved an average of 20+ user issues monthly}, providing timely technical support and troubleshooting to key commercial and academic stakeholders, thereby enhancing user satisfaction and productivity.
    \item \textbf{Contributed to the development of training materials} such as tutorials, documentation, and presentations, enhancing the learning experience for new users and improving knowledge transfer within the organization.
    \item \textbf{Collaborated with product development teams} by providing user feedback and insights, contributing to software improvements and ensuring that the platform met the evolving needs of the scientific community.
    \item \textbf{Proactively identified and documented common user challenges} and developed solutions, contributing to the creation of a comprehensive knowledge base and reducing the volume of repetitive support requests.
\end{itemize}

\cvsection{Education}
\cvevent{Ph.D. in Biotechnology}{Vellore Institute of Technology}{2016 -- 2024}{Vellore, India}
\begin{itemize}
\item \textbf{Interdisciplinary Approach to Antidiabetic Drug Discovery:} Advanced antidiabetic therapeutic development through an integrated strategy combining computational drug design, phytochemistry, and bioformulation. This research involved: (1) identifying potent $\alpha$-amylase inhibitors using molecular modeling and machine learning; (2) exploring the therapeutic potential of \textit{Cassia angustifolia} via virtual screening and molecular dynamics; and (3) evaluating natural polymers (e.g., cyclodextrin) to improve insulin stability for oral delivery. 
\end{itemize}
\cvevent{M.Pharm. in Medicinal Chemistry}{The Tamil Nadu Dr. M.G.R. Medical University, Madras Medical College}{2009 -- 2011}{Chennai, India}
\begin{itemize}
\item \textbf{Dual inhibitor design of Aurora Kinase Subtypes A and B:}
This study identified dual inhibitors of Aurora kinase subtypes A and B. Employing molecular modeling approaches, promising scaffolds were identified through pharmacophore design, docking studies, and 3D QSAR analysis. These scaffolds were subsequently synthesized, characterized, and biologically evaluated. This research aimed to achieve dual inhibition of Aurora kinase A and B, providing insights into potential therapeutic candidates.
\end{itemize}
\cvevent{B.Pharm. in Pharmacy}{The Tamil Nadu Dr. M.G.R. Medical University, Padmavathi College of Pharmacy}{2004 -- 2008}{Dharmapuri, India}
\begin{itemize}
\item \textbf{Evaluated Anthelmintic Activity of \textit{Cissus quadrangularis} Linn. (Stem):} Conducted a comprehensive computational phytochemistry study to evaluate the anthelmintic activity of \textit{Cissus quadrangularis} Linn. (stem), employing molecular docking, phytochemical analysis, thin-layer chromatography (TLC), and pharmacological assessment.
\end{itemize}


% --- Leadership and Strategy (Expanded with examples) ---
\cvsection{Leadership and Strategy}
\begin{itemize}
    \item \textbf{Developed and implemented strategic computational chemistry initiatives} aligned with organizational objectives, resulting in enhanced research efficiency and the launch of new research programs in PROTACs and enzyme substrate engineering.
    \item \textbf{Led and mentored cross-functional teams} of computational chemists, solution architects, and coding engineers, fostering internal innovation and enabling scalable data solutions. Further collaborated with client-side chemists and biologists to ensure timely project delivery and achievement of milestones.
    \item \textbf{Spearheaded AI/ML integration} into drug discovery workflows, transforming traditional methodologies and accelerating lead identification, achieving a \textbf{35\% reduction in overall project costs}.
    \item \textbf{Delivered expert scientific consulting} in computational chemistry to pharmaceutical R\&D organizations and CROs across the APAC region.
    \item \textbf {Developed and maintained strong relationships} with key stakeholders at CRO/CDMO partners, fostering effective communication and collaboration.
    \item \textbf{Orchestrated key international scientific events} (conferences, workshops, and webinars), leveraging technical presentations to promote company offerings and drive a \textbf{20\% year-over-year increase in prospect engagement}.
    \item \textbf{Oversaw an annual employee skill and technical learning budget of \$50,000}, maximizing its impact on employee development and continuous learning.
    \item \textbf{Implemented cost-effective strategies for cloud computing resources} used in large-scale virtual screening and molecular dynamics simulations, optimizing resource utilization through priority queues and streamlined protocols without compromising performance, resulting in significant cost savings.
   \item \textbf{Cultivated a thriving community platform} focused on bridging the gap between academia and industry, empowering students to develop critical soft skills and professional competencies essential for successful commercial careers, while also providing networking opportunities and facilitating connections with potential future employers.
\end{itemize}

% --- DMTA Cycle Expertise (New Section) ---
\cvsection{DMTA Cycle Expertise}
Proven ability to leverage computational tools and techniques to optimize each stage of the DMTA cycle, including:
\begin{itemize}
    \item \textbf{Design:} Structure-based and ligand-based design, Large Scale virtual screening, molecular docking, molecular dynamics.
    \item \textbf{ Make or Synthesis:} Predicting reaction kinetics along with physicochemical properties and providing insights to guide synthetic routes using quantum mechanics Transition state search. Capable of applying generative AI encoders to explore new chemical space.
    \item \textbf{Test (In Silico or Experimental Assays):} ADME/Tox prediction, target binding affinity prediction using FEP+.
    \item \textbf{Analyze:} Exploratory data analysis on experimental outcomes, establishing rational SAR analysis, setting bench marking studies for rational decision making, and visualisation to inform subsequent design iterations using SAR, 2D-3D QSAR, FEP+ , quantum mechanics and umbrella sampling/meta dynamics based drug binding/ unbinding.
\end{itemize}

% --- Core Competencies (Reordered and Enhanced) ---
\cvsection{Core Competencies}
\begin{itemize}
    \item \textbf{Leverage machine learning integrated with physics-based modeling} to accelerate drug discovery processes.
    \item \textbf{Proficiently handle diverse chemical scaffolds}, including organometallics, heterocycles, and peptides.
    \item \textbf{Provide strategic leadership} in multidisciplinary research environments.
    \item \textbf{Expert in cheminformatics analysis} and large-scale data management.
    \item \textbf{Analyze protein-substrate binding kinetics} to drive stereoselective enzymatic catalytic synthesis.
    \item \textbf{Apply active learning to high-throughput screening and free energy molecular simulations} to optimize experimental design and maximize data output.
    \item \textbf{Manage projects effectively} using industry-standard tools such as Jira, Asana, and Podio, while adhering to regulatory processes.
    \item \textbf{Serve as the Lead Computational Science Expert for the APAC region}, specialising in computationally driven drug design methodologies.
\end{itemize}

\cvsection{Domain Expertise}
\hspace*{-1em}
\wheelchart{1.5cm}{0.5cm}{%
    20/11em/accent!40/Structure-Based Drug Design,
    25/9em/accent!60/Ligand-Based Drug Design,
    30/9em/accent/Cheminformatics,
    15/11em/accent!30/Molecular Dynamics,
    10/13em/accent!20/Quantum Mechanics
}
\cvsection{Pipeline Expertise}
\begin{itemize}
    \item \textbf{Target Identification and Validation:} Identified and validated novel drug targets using bioinformatics and proteomics approaches, contributing to the initiation of new drug discovery programs.
    \item \textbf{Hit-to-Lead Optimization:} Optimized hit compounds into lead candidates by applying structure-activity relationship (SAR) analysis, molecular modeling, and medicinal chemistry principles, improving potency, selectivity, and pharmacokinetic properties.
    \item \textbf{ADME/Tox Profiling:} Conducted comprehensive ADME/Tox profiling of lead compounds using in silico, assessing drug absorption, distribution, metabolism, excretion, and toxicity to ensure candidate molecule safety and efficacy.
\end{itemize}

\cvsection{Therapeutic Areas of Expertise}
\begin{itemize}
    \item \textbf{Oncology (Cancer):} Expertise in computational studies related to key cancer targets, including Aurora Kinase (involved in cell division), PAR2 (implicated in tumor development and metastasis), MMP-8/9 (involved in extracellular matrix breakdown and metastasis), CD44 (associated with cancer stem cells), CREBBP bromodomain (involved in gene expression regulation), and Kinesin Spindle Protein (a target for chemotherapy).
    \item \textbf{Infectious Diseases:} Experience in computational modeling and drug discovery for infectious diseases, including Tuberculosis (targeting *Mycobacterium tuberculosis* proteins), Malaria (targeting *Plasmodium falciparum* gametocytes), and COVID-19 (targeting SARS-CoV-2 S protein and M protease).
    \item \textbf{Neurodegenerative Diseases:} Research focused on MAO-B inhibitors for the potential treatment of Parkinson's Disease.
    \item \textbf{Metabolic Disorders:} Expertise in using computational methods, including machine learning, for the design of antidiabetic molecules.
    \item \textbf{Other Areas:} Contributions to research areas including inflammation (related to MMPs and PAR2), drug delivery (computational formulation studies), Small molecule membrane permeability and envenoming (inhibition of snake venom metalloproteinase).
\end{itemize}

\cvsection{Computational Skills}
\begin{itemize}
    \item \textbf{Programming:} Python, Shell Scripting,GIT 
    \item \textbf{AI/ML Frameworks:} TensorFlow, PyTorch, Scikit-learn, DeepChem
    \item \textbf{Tools:} Schrödinger Suite, KNIME, GROMACS, AutoDock, Pymol.
    \item \textbf{Platforms:} AWS, GCP, Linux/Unix
    \item \textbf{Project Management:} Asana, Podio, Live Design
\end{itemize}

\cvsection{Key Achievements}
\begin{itemize}
    \item \textbf{Innovative Drug Discovery:} Led the design and optimization of novel lead compounds, advancing multiple therapeutic programs to preclinical development across oncology and metabolic disorders.
    \item \textbf{AI/ML Integration:} Developed and deployed machine learning and deep learning models for toxicity prediction, QSAR enhancement, and drug metabolism analysis, reducing experimental timelines by 30\%.
    \item \textbf{Leadership Excellence:} Directed cross-functional teams of chemists, biologists, and data scientists to achieve critical milestones ahead of schedule, while mentoring over 15 early-career scientists.
    \item \textbf{Technical Innovations:} Designed a computational framework combining free energy calculations, molecular dynamics simulations, and AI-driven modeling, significantly boosting hit-to-lead success rates.
    \item \textbf{Therapeutic Impact:} Rescued and re-optimized stalled immuno-oncology programs through computational insights, contributing to novel therapies in high-stakes areas.
    \item \textbf{Client and Stakeholder Engagement:} Partnered with industry leaders to co-develop advanced solutions, strengthening client relationships and expanding organizational influence.
    \item \textbf{Recognition and Dissemination:} Published 40+ research articles in high-impact journals and delivered invited talks at international conferences on AI applications in computational drug discovery.
\end{itemize}

\cvsection{Certifications and Training}
\begin{itemize}
    \item \textbf{Data Science and Machine Learning:} Completed coursework in core data science and machine learning concepts, including statistical learning, supervised and unsupervised learning algorithms, and model evaluation. Courses include: Introduction to Data Science in Python (Coursera), Fundamentals of Machine Learning with Python, Machine Learning Fundamentals, Supervised Learning with \texttt{scikit-learn}, and Unsupervised Learning in Python (DataCamp).
    \item \textbf{Python Programming and Data Manipulation:} Developed proficiency in Python programming for data science, including data manipulation with \texttt{pandas}, data cleaning, and data import/export. Courses include: Introduction to Python, Intermediate Python for Data Science, Importing Data in Python (Parts 1 \& 2), Python Data Science Toolbox (Part 1), Cleaning Data in Python, Manipulating DataFrames with \texttt{pandas}, Merging Dataframes with \texttt{pandas}, and Pandas Foundation (DataCamp).
    \item \textbf{Data Analysis and Databases:} Gained experience in data analysis techniques using \texttt{pandas} and SQL, including statistical analysis and data visualization. Courses include: Analyzing Police Activity with \texttt{pandas}, Intro to SQL for Data Science, and Statistical Thinking in Python (DataCamp).
    \item \textbf{Cloud Computing and Software Management:} Completed training in cloud computing fundamentals and AWS Boto, as well as software environment management with Conda. Courses include: Cloud Computing for Everyone, Introduction to AWS Boto, and Conda Essentials (DataCamp).
\end{itemize}

\cvsection{Selected Publications}
\begin{itemize}
    \item \textbf{AI/ML in Drug Discovery (with Experimental Validation):} \textbf{Devaraji, V.}, Sivaraman, J., et al. Exploring the potential of machine learning to design antidiabetic molecules: a comprehensive study with experimental validation, \textit{Journal of Biomolecular Structure and Dynamics}, \textbf{42}(23), 13290--13311, 2024.
    \item \textbf{Structure-Based Drug Design and Target Analysis:} Kakarala, K., Jamil, K., \textbf{Devaraji, Vinod}, Structure and signaling mechanism of PAR2, \textit{Journal of Molecular Graphics and Modelling}, \textbf{53}, 179--199, 2014.
    \item \textbf{Structure- and Ligand-Based Drug Design with MD:} Kalva, S., \textbf{Vinod, D.}, et al. Combined structure-and ligand-based pharmacophore modeling, \textit{Journal of Molecular Modeling}, \textbf{20}(5), 1--18, 2014.
    \item \textbf{Virtual Screening and Lead Discovery:} Raghu, R., \textbf{Devaraji, Vinod}, et al. Virtual screening and discovery of novel aurora kinase inhibitors, \textit{Current Topics in Medicinal Chemistry}, \textbf{14}(17), 2006--2019, 2014.
    \item \textbf{Molecular Docking and Simulation (SARS-CoV-2):} James, J. P., \textbf{Devaraji, Vinod}, et al. In silico Exploration of Dakshina Kannada Medicinal Plants as Anti-SARS-CoV-2 Agents by Molecular Docking and Simulation Approaches, \textit{Letters in Drug Design \& Discovery}, \textbf{20}(10), 1544--1556, 2023.
    \item \textbf{Molecular Dynamics, Free Energy, and Synthesis/Bioevaluation:} Ranade, S. D., Alegaon, S. G., et al. Design, synthesis, molecular dynamics simulation, MM/GBSA studies and kinesin spindle protein inhibitory evaluation of some 4-aminoquinoline hybrids. \textit{Computational Biology and Chemistry}, \textbf{105}, 107881, 2023.
    \item \textbf{Computational Studies, Physicochemical Properties, and Synthesis:} Kumar, H., \textbf{Devaraji, Vinod}, et al. Design, synthesis, physicochemical studies, solvation, and DNA damage of quinoline-appended chalcone derivative: comprehensive spectroscopic approach toward drug discovery, \textit{The Journal of Physical Chemistry B}, \textbf{118}(26), 7257--7266, 2014.
    \item \textbf{Computational Studies on a Drug Target (SARS-CoV-2):} Jena, A. B., \textbf{Devaraji, V.}, et al. Computational Insight on 8-HDS, \textit{Chemistry \& Biodiversity}, \textbf{19}(11), e202200266, 2022.
    \item \textbf{Computational Formulation Studies:} \textbf{Devaraji, Vinod}, Jayanthi, S. Computational formulation study of insulin on biodegradable polymers, \textit{RSC advances}, \textbf{13}(29), 20282--20297, 2023.
    \item \textbf{Synthesis, Characterization, and Biological Evaluation:} Alegaon, S. G., Alagawadi, K. R., Pawar, S. M., \textbf{Vinod, D.}, and Rajput, U. Synthesis, characterization, and biological evaluation of thiazolidine-2, 4-dione derivatives. \textit{Medicinal Chemistry Research}, \textbf{23}, 987–994, 2014. % "and" used here
    \item \textbf{Synthesis, Pharmacophore Modeling, and Cytotoxic Activity:} Alegaon, S. G., Alagawadi, K. R., \textbf{Vinod, D.}, Unger, B., and Khatib, N. A. Synthesis, pharmacophore modeling, and cytotoxic activity of 2-thioxothiazolidin-4-one derivatives. \textit{Medicinal Chemistry Research}, \textbf{23}, 5160–5173, 2014. % "and" used here
    \item \textbf{Hypnotic Profile with Synthesis and in silico Screening:} Mathew, B., Suresh, J., Anbazhagan, S., and \textbf{Devaraji, V.} Hypnotic Profile of Imines from Benzimidazole Chalcones: Mechanism of Synthesis, DFT Studies and in silico Screening. *Central Nervous System Agents in Medicinal Chemistry*, *13*(3), 207–216, 2013. % "and" used here
\end{itemize}

\cvsection{Referees}
Available upon request.

\cvsection{Declaration}
I hereby declare that the information provided is accurate to the best of my knowledge and belief.

\vspace{1em}
\textbf{Vinod Devaraji} \\
\textit{Bangalore, India}\\
\today

\end{document}